C. DURAN Et Al. , "Combination or single usage of fenofibrate and rosiglitazone in the treatment of type 2 diabetic subjects with hyperlipidemia," The Anatolian Journal of Clinical Investigation , vol.1, no.1, pp.18-24, 2006
DURAN, C. Et Al. 2006. Combination or single usage of fenofibrate and rosiglitazone in the treatment of type 2 diabetic subjects with hyperlipidemia. The Anatolian Journal of Clinical Investigation , vol.1, no.1 , 18-24.
DURAN, C., ERSOY, C., Tuncel, E., KÜÇÜKSARAÇ KIYICI, D. S., Selimoğlu, H., ÖZKAYA, G., ... ÖZ GÜL, Ö.(2006). Combination or single usage of fenofibrate and rosiglitazone in the treatment of type 2 diabetic subjects with hyperlipidemia. The Anatolian Journal of Clinical Investigation , vol.1, no.1, 18-24.
DURAN, CEVDET Et Al. "Combination or single usage of fenofibrate and rosiglitazone in the treatment of type 2 diabetic subjects with hyperlipidemia," The Anatolian Journal of Clinical Investigation , vol.1, no.1, 18-24, 2006
DURAN, CEVDET Et Al. "Combination or single usage of fenofibrate and rosiglitazone in the treatment of type 2 diabetic subjects with hyperlipidemia." The Anatolian Journal of Clinical Investigation , vol.1, no.1, pp.18-24, 2006
DURAN, C. Et Al. (2006) . "Combination or single usage of fenofibrate and rosiglitazone in the treatment of type 2 diabetic subjects with hyperlipidemia." The Anatolian Journal of Clinical Investigation , vol.1, no.1, pp.18-24.
@article{article, author={CEVDET DURAN Et Al. }, title={Combination or single usage of fenofibrate and rosiglitazone in the treatment of type 2 diabetic subjects with hyperlipidemia}, journal={The Anatolian Journal of Clinical Investigation}, year=2006, pages={18-24} }